Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation

(2010) S. L. Galper et al.   BLOOD

Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage

(2010) Carrie Anna Geisberg et al.   CURRENT HYPERTENSION REPORTS

Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

(2010) Thomas Eschenhagen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

(2010) Daniela Cardinale et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracycline-Induced Cardiomyopathy

(2010) Daniela Cardinale et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION

(2010) Winston W. Huh et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

(2009) A L Jones et al.   BRITISH JOURNAL OF CANCER

Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials

(2009) Edith A. Perez et al.   MAYO CLINIC PROCEEDINGS

Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations

(2009) M. Martin et al.   ONCOLOGIST

Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems

(2008) B. R.J. H. Bird et al.   CLINICAL CANCER RESEARCH

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

(2008) Edith A. Perez et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma

(2008) Manuela Schmidinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation

(2007) J.-J. Mourad et al.   ANNALS OF ONCOLOGY

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer

(2007) Federica Cuppone et al.   CANCER

Drug-induced QTc interval prolongation: A proposal towards an efficient and safe anticancer drug development

(2007) Giuseppe Curigliano et al.   EUROPEAN JOURNAL OF CANCER